Fortrea Holdings Inc. (NASDAQ:FTRE), a leading contract research organization (CRO) spun off from Labcorp (NYSE:LH) in mid-2023, has been navigating a complex landscape in the life sciences industry. The company, which provides outsourced R&D services to pharmaceutical, biotechnology, medical device, and diagnostics industries, has faced challenges in its biotech segment while experiencing strength in its large pharma business.
Company Overview and Recent Performance
Fortrea operates in…
Read More…
CRO stock faces biotech headwinds, pharma strength By Investing.com
